{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:52:32Z","timestamp":1761807152587,"version":"3.32.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1136\/ard.2005.036459","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T00:24:31Z","timestamp":1114043071000},"page":"1765-1768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Do steroids increase lymphoma risk? A case\u2013control study of lymphoma risk in polymyalgia rheumatica\/giant cell arteritis"],"prefix":"10.1016","volume":"64","author":[{"given":"J","family":"Askling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Klareskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Baecklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ekbom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2005.036459_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0145-2126(98)80012-X","article-title":"Non-Hodgkin\u2019s lymphoma: case control epidemiological study in Yorkshire","volume":"12","author":"Cartwright","year":"1988","journal-title":"Leuk Res"},{"key":"10.1136\/ard.2005.036459_bib2","first-page":"5510","article-title":"Prior medication use and health history as risk factors for non-Hodgkin\u2019s lymphoma: preliminary results from a case-control study in Los Angeles County","volume":"52","author":"Bernstein","year":"1992","journal-title":"Cancer Res"},{"key":"10.1136\/ard.2005.036459_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/B:CACO.0000027506.55846.5d","article-title":"Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women","volume":"15","author":"Zhang","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1136\/ard.2005.036459_bib4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1021953224822","article-title":"Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin\u2019s lymphoma (NHL) (United States)","volume":"13","author":"Kato","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1136\/ard.2005.036459_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/aje\/kwg145","article-title":"Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco","volume":"158","author":"Holly","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1136\/ard.2005.036459_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1023\/A:1025698109991","article-title":"No increased risk of non-Hodgkin\u2019s lymphoma with steroids, estrogens and psychotropics (Netherlands)","volume":"14","author":"Beiderbeck","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1136\/ard.2005.036459_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/djh118","article-title":"Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study","volume":"96","author":"Sorensen","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ard.2005.036459_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.10939","article-title":"Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives","volume":"48","author":"Ekstrom","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.036459_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/03009740252937568","article-title":"Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus","volume":"31","author":"Bjornadal","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2005.036459_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ijc.2910600209","article-title":"Cancer risk after renal transplantation in the Nordic countries, 1964\u20131986","volume":"60","author":"Birkeland","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1136\/ard.2005.036459_bib11","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","article-title":"Hodgkin\u2019s disease and lymphoproliferations resembling Hodgkin\u2019s disease in patients receiving long-term low-dose methotrexate therapy","volume":"20","author":"Kamel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ard.2005.036459_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.317.7152.180","article-title":"Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study","volume":"317","author":"Baecklund","year":"1998","journal-title":"BMJ"},{"key":"10.1136\/ard.2005.036459_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","article-title":"Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment","volume":"78","author":"Kinlen","year":"1985","journal-title":"Am J Med"},{"issue":"suppl 1","key":"10.1136\/ard.2005.036459_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ard.41.Suppl_1.12","article-title":"The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens","volume":"41","author":"Hazleman","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2005.036459_bib15","first-page":"1705","article-title":"Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases","volume":"26","author":"Asten","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2005.036459_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"139","author":"Weyand","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2005.036459_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.42.4.374","article-title":"Polymyalgia rheumatica and corticosteroids: how much for how long?","volume":"42","author":"Behn","year":"1983","journal-title":"Ann Rheum Dis"},{"issue":"6 suppl 32","key":"10.1136\/ard.2005.036459_bib18","first-page":"S29","article-title":"The role of disease-modifying antirheumatic drugs in the treatment of giant cell arteritis","volume":"21","author":"Nuenninghoff","year":"2003","journal-title":"Clin Exp Rheumatol"},{"year":"1998","series-title":"Patientregistret 1987\u20131996 Kvalitet och innehall","key":"10.1136\/ard.2005.036459_bib19"},{"key":"10.1136\/ard.2005.036459_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/02841868409136026","article-title":"Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978","volume":"23","author":"Mattsson","year":"1984","journal-title":"Acta Radiol Oncol"},{"year":"1955","series-title":"International classification of diseases","key":"10.1136\/ard.2005.036459_bib21"},{"key":"10.1136\/ard.2005.036459_bib22","first-page":"1","article-title":"The person-number systems of Sweden, Norway, Denmark, and Israel","volume":"2","author":"Lunde","year":"1980","journal-title":"Vital Health Stat 2"},{"key":"10.1136\/ard.2005.036459_bib23","first-page":"2143","article-title":"No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls","volume":"29","author":"Myklebust","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2005.036459_bib24","first-page":"1335","article-title":"Cancer in association with polymyalgia rheumatica and temporal arteritis","volume":"20","author":"Haga","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2005.036459_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/rheumatology\/34.3.261","article-title":"Epidemiology and mortality in 220 patients with polymyalgia rheumatica","volume":"34","author":"Schaufelberger","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2005.036459_bib26","first-page":"205","article-title":"Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy","volume":"5","author":"Salvarani","year":"1987","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2005.036459_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","article-title":"Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort","volume":"100","author":"Matteson","year":"1996","journal-title":"Am J Med"},{"key":"10.1136\/ard.2005.036459_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"issue":"suppl 9","key":"10.1136\/ard.2005.036459_bib29","first-page":"188","article-title":"Inflammatory activity, but not methotrexate or prednisone use predicts non-Hodgkin\u2019s lymphoma in rheumatoid arthritis","volume":"41","author":"Wolfe","year":"1998","journal-title":"Arthritis & Rheumatism"},{"issue":"suppl 1","key":"10.1136\/ard.2005.036459_bib30","first-page":"103","article-title":"Disease activity, but not DMARD use, increases the risk for malignant lymphoma in rheumatoid arthritis: a case-control study of 378 RA lymphoma patients","volume":"63","author":"Baecklund","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2005.036459_bib31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ijc.11311","article-title":"Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma","volume":"106","author":"Cerhan","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1136\/ard.2005.036459_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ijc.10444","article-title":"Cancer incidence in a population-based cohort of patients with Wegener\u2019s granulomatosis","volume":"100","author":"Knight","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1136\/ard.2005.036459_bib33","first-page":"906","article-title":"Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964\u201395","volume":"29","author":"Bjornadal","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2005.036459_bib34","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/38.12.1208","article-title":"The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations","volume":"38","author":"Petursdottir","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2005.036459_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"issue":"4 suppl 20","key":"10.1136\/ard.2005.036459_bib36","first-page":"S22","article-title":"Giant cell arteritis and polymyalgia rheumatica: role of viral infections","volume":"18","author":"Duhaut","year":"2000","journal-title":"Clin Exp Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724203708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724203708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2005.036459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T14:37:58Z","timestamp":1736087878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724203708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0003496724203708"],"URL":"https:\/\/doi.org\/10.1136\/ard.2005.036459","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do steroids increase lymphoma risk? A case\u2013control study of lymphoma risk in polymyalgia rheumatica\/giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2005.036459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}